1 Magnificent Stock That Turned $1,000 Into $41,500

Well Health is a TSX stock which has delivered multi-fold returns to shareholders in the last seven years. Is WELL stock a good buy today?

| More on:
dividends grow over time

Source: Getty Images

Growth stocks have the potential to generate outsized gains for long-term investors. For instance, since its IPO (initial public offering) in 2016, Well Health (TSX:WELL) stock has returned over 4,000% to shareholders. It suggests a $1,000 investment in WELL stock in 2016 would be worth $41,500 today. Comparatively, a similar investment in the TSX index would be worth less than $2,000 today.

However, a volatile stock market has also driven valuations of growth stocks lower in the past 20 months. Despite its market-beating gains, WELL stock is down 55% from all-time highs, valuing it at a market cap of $985 million.

While Well Health stock has delivered exponential returns to shareholders, let’s see if the TSX stock remains a compelling bet for investors at its current valuation.

Is Well Health stock a good buy right now?

Well Health aims to leverage the power of technology to disrupt the legacy healthcare segment and improve patient outcomes. It is focused on improving efficiencies for healthcare providers by providing a robust practitioner enablement platform.

The company offers a comprehensive end-to-end healthcare system in Canada. It is the largest outpatient medical clinic owner-operator in the country, and its portfolio of services includes primary care, specialist care, allied care, and diagnostics.

Well Health provides two-way access to records, which results in better communication outcomes for patients and healthcare providers. The company targets high-cost structures in clinics with its expertise in technology, leading to higher profits and cash flows.

Moreover, healthcare providers spend 50% of their time on manual, non-digital tasks which can be automated. Around 50% of providers attribute burnout to manual tasks, which include paperwork and charting. Further, 55% of providers claim their individual time with patients has declined over time due to admin-related tasks.

Well Health also provides omni-channel healthcare solutions in the U.S. For example, it is among the largest providers of anesthesia services to gastroenterologists and has a presence in 48 states south of the border.

Well Health has successfully provided solutions to target industry-wide issues, allowing the company to increase sales from $32.8 million in 2019 to $569 million in 2022.

What is the target price for Well Health stock?

The healthcare disruptor has focused on highly accretive acquisition to grow its top line and gain traction in the U.S. Well Health continues to grow at an enviable pace and reported revenue of $171 million with an adjusted EBITDA (earnings before interest, tax, depreciation, and amortization) of $27.8 million.

The company surpassed one million patient visits for the first time in the June quarter and ended the second quarter with 5.9 million patient interactions on an annualized run-rate basis. Well Health’s subsidiary OceanMD also signed a $38.5 million multi-year contract to provide e-referral and e-order tech services in British Columbia.

It is now forecast to end 2023 with revenue between $740 million and $760 million. This expansion in revenue should allow Well Health to improve profitability. Analysts expect adjusted earnings to improve from $0.05 per share in 2023 to $0.13 per share in 2024.

Well Health stock is priced at 1.2 times forward sales and 32 times forward earnings, which is very cheap for a growth stock. Analysts remain bullish and expect shares to almost double in the next 12 months.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Aditya Raghunath has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

More on Tech Stocks

tsx today
Tech Stocks

TSX Today: What to Watch for in Stocks on Tuesday, December 5

The key job openings data from the United States could give further direction to TSX stocks today.

Read more »

Male IT Specialist Holds Laptop and Discusses Work with Female Server Technician. They're Standing in Data Center, Rack Server Cabinet with Cloud Server Icon and Visualization
Tech Stocks

2 Top Technology Stocks to Buy on the TSX Today

These TSX technology stocks have high growth potential, making them worthy candidates for buying now.

Read more »

funds, money, nest egg
Dividend Stocks

3 Stocks to Turn $1K Into $5K in 2024

Three stocks that outperform this year amid massive headwinds could deliver far superior returns in 2024.

Read more »

Businessman holding AI cloud
Tech Stocks

4 AI Stocks Transforming the Future

Four TSX stocks are the top prospects if you expect to ride and make money on the anticipated AI boom…

Read more »

Technology, internet and networking, security concept
Tech Stocks

Earn as Much as 110% in 2024 (While Keeping the CRA Away)

Holding quality tech stocks such as Nuvei and CrowdStrike in a TFSA is a great strategy to build long-term wealth.

Read more »

question marks written reminders tickets
Tech Stocks

Up 37 Percent in 2023: Is OpenText Stock a Buy Now?

OpenText’s latest spin-off deal uniquely makes the Canadian tech giant an astute, yet unintentional stock trader.

Read more »

edit Sale sign, value, discount
Dividend Stocks

3 Remarkably Cheap TSX Stocks to Buy Right Now

These three cheap TSX stocks are some of the best buys on the TSX, and yet their share price is…

Read more »

Family relationship with bond and care
Dividend Stocks

TFSA Investors: 3 Cheap Canadian Stocks for Retirees

These three Canadian stocks are super cheap for retirees looking for a great buy that will last the test of…

Read more »